SYED SAJJAD ZAIDI: Open Payments
NPI 1083806681 · ALVIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 16 payments from 7 companies in 2025. Trend: 2023 $213 · 2024 $430 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $229 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Lundbeck LLC | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Tempus AI, Inc | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: CAPLYTA, REXULTI, FANAPT, Qelbree, TEMPUS PIXEL, UZEDY.
Industry payments across TX — which companies pay providers there.
